who invented glp 1 drugs Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88 Lotte Bjerre Knudsen: The Scientist

Glp-1 receptor agonists (Glp-1ras): Cardiovascular actions and therapeutic potential

Importantly, pro-oxidant NAC effects were not observed at concentrations of 50 or 500 mg/kg making pro-oxidative actions of NAC in present study highly unlikely

But some people, particularly those with absorption issues or those with a diet lacking in animal products, may need to find supplemental sources of vitamin B12

The peptide does not suppress natural hormone production, cause organ toxicity at therapeutic doses, or produce withdrawal effects upon discontinuation

Diabetic central neuropathy: CNS damage related to hyperglycemia